Kathleen McDermott, RN, BSN, OCN, BMTCN
Authored Items
November 14, 2017 | November 2017 Vol 8, No 11
Chimeric antigen receptor (CAR) T cells are engineered from a patient’s own immune cells to redirect them to attack tumor cells.
Last modified: June 5, 2018